The Nebulizer Devices Market To Witness A Handsome A CAGR Of 6.6%

Posted by Merin John on May 31st, 2021

The Nebulizer Devices Market report by Persistence Market Research takes into consideration the healthcare industry’s transformation concerning services, infrastructure, coupled with support extended from the governments all across. Technological advancements are capable of catering to patients on an urgent basis. As such, both – stress and time could be saved.

Persistence Market Research (PMR) has recently published a research report titled “Nebulizer Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” The report states that the global nebulizer devices market is expected to witness a stable growth in the coming years. Advances in healthcare and the introduction of new drugs has been anticipated to trigger the adoption of nebulizer devices until 2025 end, thus supporting the overall growth of the market.

With technological advances rapidly gaining pace, key players in the market are also rolling up their sleeves in order to sustain in the intensifying market scenario and also to stay ahead of the competition. Companies are investing in research and development of new products and are focusing on mergers, acquisitions, and partnerships.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/22411

Company Profiles

•          Agilent Technologies, Inc.
•          Allied Healthcare Products, Inc.
•          CareFusion Corporation (sub. Becton, Dickinson and Company)
•          Covidien plc (sub. Medtronic)
•          GE Healthcare
•          GF Health Products Inc.
•          Omron Healthcare, Inc.
•          PARI GmbH
•          Koninklijke Philips N.V.

For instance, in 2015, two market giants Agilent Technologies Inc. and Thermo Fisher Scientific entered into an agreement for instrument control exchange. This agreement proved to be beneficial with improved productivity and enhanced user experience for customers who were using the instruments and software of both the companies. Many other agreements and exchange partnerships have taken place between several leading firms.

On these grounds, the global nebulizer devices market is expected to expand at 6.6% CAGR from 2017 to 2025. The market is projected to rise to a valuation of over US$ 3,382 Mn by the end of 2025 from a valuation of around US$ 2,033 Mn in 2017.